Effect of Pioglitazone With and Without Exenatide on Body Weight, Fat Topography, Beta Cell Function, and Glycemic Control in Type 2 Diabetic Patients
Phase of Trial: Phase IV
Latest Information Update: 03 Nov 2017
At a glance
- Drugs Exenatide (Primary) ; Pioglitazone (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics; Therapeutic Use
- Acronyms PIO-EX
- 10 Jun 2017 Biomarkers information updated
- 28 Jun 2011 Results presented at the 71st Annual Scientific Sessions of the American Diabetes Association.
- 21 Jul 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.